Science Explorer Back to mapMap

Most cited papers from Orbus Therapeutics (United States)

Orbus Therapeutics (United States)

What are the most cited papers from Orbus Therapeutics (United States)?

The most cited paper from Orbus Therapeutics (United States) is "Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update" (Jaishri O'Neill Blakeley et al., 2025), with 15 citations. Next come "Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma" (10) and "Integrating Human Intestinal Organoids into FDA's New Approach Methodologies for Drug Discovery" (4).

Showing 9 of 9 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline Rapid Recommendation Update Jaishri O'Neill Blakeley et al. · Journal of Clinical Oncology Open access 29 Apr 2025 15
2 Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma Joe Sammy Mendez et al. · Neuro-Oncology Advances Open access 2024 10
3 Integrating Human Intestinal Organoids into FDA's New Approach Methodologies for Drug Discovery Debarun Patra, Ibrahim M. Sayed, Souhrid Mukherjee et al. · Advanced Science Open access 2 Mar 2026 4
4 A scoping review of the treatment of hypertrophic scars and keloids Benjamin Michael Davies, Alison R. Carter, David A. Brindley · Dermatological Reviews Open access 21 Feb 2022 4
5 Effect of eflornithine on mutation frequency in temozolomide-treated U87MG cells Noymi Yam, Jason Levin, Zheng‐Zheng Bao et al. · Oncotarget Open access 3 Nov 2020 3
6 Basics of Stem Cells and Preclinical Testing K. Suryanarayana Rao · Biology Engineering Medicine and Science Reports Open access 20 Sep 2017 2
7 Asporin Improves Cardiac Myocyte Response to Ischemia and Reperfusion Stress Deepika Rai, Mukta Basu, Liam McCarthy et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 24 Jan 2026 0
8 CTNI-58. UPDATED RESULTS OF PHASE 3 STELLAR TRIAL: EFLORNITHINE IMPROVES OVERALL SURVIVAL AND BLINDED INDEPENDENT CENTRAL REVIEW DETERMINED PROGRESSION FREE SURVIVAL IN PATIENTS WITH RECURRENT WHO 2021 GRADE 3 IDH-MUTANT ASTROCYTOMA Howard Colman et al. · Neuro-Oncology Open access Nov 2025 0
9 Practical Considerations in the Conduct of Micronucleus Test K. Suryanarayana Rao · Biology Engineering Medicine and Science Reports Open access 20 Sep 2017 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.